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P. Boli and R. Campbell discuss whether recommendations
for the management (and control) of high blood pressure
really result in improved cardiovascular (CV) outcomes.
Adherence to the recommendations by the Canadian Hyper-
tension Education Program did signiﬁcantly improve all
the aspects (awareness, treatment, and control) of hyper-
tension, as well as mortality and hospitalization due to
strokes, heart failure, and myocardial infarction. The authors
suggest that application of similar recommendations for
the management and control of hypertension in other
regions of the world may be helpful. An interesting paper
by C. Sierra reviewed that presence of cerebral white
matter lesions (usually found in the aged population)
were more severe and appeared early in patients with
high blood pressure. There was an association between
blood pressure parameters obtained by ambulatory blood
pressure monitoring (ABPM) and presence of white matter
lesions, suggesting that data obtained from ABPM may be
helpful in identifying asymptomatic hypertensive patients
with brain damage. R. Fagugli and C. Taglioni discuss that
aldosteronism (hyperaldosteronism), which was thought to
be rare (aﬀecting 1% of the hypertensive population), occurs
at a much higher incidence (5–20%) in patients with type 2
diabetics and resistant hypertension and is associated with
a high incidence of cardiovascular (CV), cerebrovascular,
and kidney complications. The variation in the estimates of
prevalence may be due to methodology and deﬁnitions. M.
Roy et al. determined that among African Americans with
type 1 diabetes mellitus, without elevated blood pressure,
29% develop hypertension in the course of 6 years. The
risk factors associated with the development of hypertension
include age, duration of diabetes, family history of hyper-
tension, higher baseline arterial pressure, overt proteinuria,
presence of retinopathy or peripheral neuropathy, smoking,
and psychological factors, such as perceived hostility. An
interesting paper by M. Yamori et al. investigated the
association of hypertension with periodontitis and/or tooth
loss (apparently from periodontal disease) in a group of
nonsmoking, nondrinking middle-aged African women.
Their studies show that the severity of periodontal disease
was signiﬁcantly associated with increased systolic and
diastolic blood pressure. In addition, low dietary intake of
potassiumandﬁberwasdirectlyassociatedwithhigherblood
pressure and periodontal inﬂammation. On the other hand,
higher dietary intake of potassium, fruits, and vegetables
decreased inﬂammation of the gums. The authors suggest
that increased dietary intake of potassium, fruits, and vegeta-
bles may decrease the incidence of periodontitis. Q. Nguyen
and coworkers analyzed cardiovascular risk factors in a large
cross-sectional survey in Vietnam. The prevalence of the
clustering of metabolic (such as in the metabolic syndrome)
and behavioral risk factors was more prevalent in men than
in women, and there was a 4-fold higher overall 10-year
CV risk in men than in women. Targeting only a single risk
factorwouldnotdecreasetheoverallrisk.Apharmacological
means of correcting endothelial dysfunction was proposed
by M. Pokrovskiy et al., by the use of inhibitors of arginase
(which catalyses the degradation of L-arginine and thereby
reducing the production of nitric oxide), thus increasing
the production of the vasodilating nitric oxide, thereby
protecting the endothelium. Intheir studies in rats, R. Peroni
and coworkers observed that phytoestrogens produced an
estrogen receptor-dependent enhancement of anandamide-
inducedreductionofcontractility(ofmesentericbed)caused
by noradrenaline by modulation of calcitonin gene-related
peptide. The in vivo suppression of adrenergic hyperactivity2 International Journal of Hypertension
(which precedes the onset of hypertension) by anandamide
(such as by oral administration of genistein or daidzein) was
observed in female but not in male rats or ovariectomized
female rats.
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